Last updated on May 2019

A Study to Evaluate SAGE-217 in Adult Subjects With Major Depressive Disorder


Brief description of study

This is a phase 3, open-label, 1-year study of the safety, tolerability, and need for re-treatment with SAGE-217 in adult subjects with major depressive disorder

Clinical Study Identifier: NCT03864614

Find a site near you

Start Over

Sage Investigational Site

Bradenton, FL United States
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.